Somebody wanted me to buy pregnenolone. The ads knew my name before I asked a question. Mood. Memory. The “mother hormone,” they called it, the one that supposedly builds every other hormone you own. Sounded like a pitch. Pitches usually are.
I don’t take a claim at face value. I take it to the file room. So I went looking for what actually backs the mood-and-memory sell, expecting either a clean win somebody buried or a clean con somebody dressed up. Neither. What I got was messier, and more honest, than a con.
One thing up front. I’m not a doctor. Nobody paid me for a white coat. This is a reported column, not a prescription pad, and I’m keeping the claims as thin as the evidence lets me. Bottom line, before I walk you through it: the mood and memory science is real, but it’s small, it lives almost entirely in psychiatric wards rather than in tired people scrolling their phones at midnight, and the only sane way near it is supervised. Now the digging.
Who put this in your feed
Pregnenolone isn’t new. Your body’s made it from cholesterol for as long as you’ve had adrenal glands. It sits at the top of a chain that builds DHEA, progesterone, cortisol, testosterone, estrogen, and a handful of brain-active neurosteroids. That part’s textbook, not marketing.
What changed is the sales climate. The optimization crowd needed upstream molecules to move, and “mother hormone” is a name that sells itself. Somewhere in the retelling, “it’s the precursor to your hormones” turned into “so it fixes your mood, your memory, your edge.” Three products emerged from the same starting compound: a cheap bottle off the shelf, a “research” powder with no chain of custody, and a compounded prescription with an actual clinician attached. Same molecule, three very different levels of accountability.
That’s the setup. Now the trials.
Four studies, and I read every one
There is real human research here. It’s just not where the sales copy points you.
Study one, out of Duke. Twenty-one patients with schizophrenia or schizoaffective disorder, already medicated, randomized to pregnenolone built up to 500 mg a day or placebo, eight weeks [P1]. On the thing it’s sold for, memory and cognition, it came up empty. Primary cognitive scores didn’t move. What it did move was negative symptoms, a mean change of 10.38 versus 2.33, p=0.048 [P1]. So the most-quoted brain study in this whole space isn’t a memory study at all. That stopped me cold.
Study two is the strongest cognitive result on file. Sixty patients with recent-onset schizophrenia, pregnenolone at a modest 50 mg a day against placebo, on top of their meds, eight weeks [P2]. This one landed: significantly reduced visual-attention deficits, p=0.002, a moderate effect size of d=0.42, plus gains on other attention and executive measures [P2]. A real signal. Still confined to a serious diagnosed illness, not to a guy who feels foggy after a bad night’s sleep.
Study three broke an assumption I didn’t know I was carrying. Fifty-eight patients with chronic schizophrenia, low-dose pregnenolone at 30 mg a day versus a much higher 200 mg a day, plus DHEA and placebo [P3]. I figured more would do more. Wrong. The 30 mg dose significantly improved positive symptoms, side effects, attention, and working memory. The 200 mg dose did nothing placebo didn’t already do [P3]. Low dose works, high dose flops, and a different trial entirely used 500 mg. Nobody’s settled the dose. That’s not a finished treatment. That’s an open file.
Study four is the mood study, and it’s the best-looking piece of paper in the stack. Eighty adults with bipolar depression, pregnenolone titrated to 500 mg a day or placebo, added onto treatment, twelve weeks [P4]. Significant improvement over time on the Hamilton depression scale, p=0.025, and more people hit remission on pregnenolone, 61% versus 37%, p=0.046, though not every measure cleared the bar [P4]. Well tolerated. The authors called it promising and unfinished. That’s the right tone, and almost nobody selling it downstream uses it.
So here’s where the trail actually ends. The evidence is real. It’s interesting. It’s boxed inside psychiatric patients, used as an add-on to real medication, at doses researchers can’t agree on, with effects that are modest at best. Nobody’s run the big trial showing pregnenolone sharpens memory or lifts mood in an otherwise healthy adult, which happens to be the exact customer buying it. Not a fraud. A research molecule wearing a finished product’s clothes.
The paperwork nobody mentions
Here’s the wrinkle that changed how I read all of it. Pregnenolone is sold two contradictory ways at once. You can buy it over the counter as a supplement, no gatekeeper, $12 and done. But the FDA’s own position is that pregnenolone is an unapproved new drug, there’s no FDA-approved pregnenolone product for anything, and the compounding pharmacies that make the stuff say so themselves, on their own pages. The FDA doesn’t sit still when supplement sellers claim to treat a disease, either. It’s sent rounds of warning letters to companies illegally selling supplements that claim to treat depression and other mental illness [P5], which lands uncomfortably close to the exact mood pitch that pulled me into this story.
Easy to buy isn’t the same as approved. It isn’t even the same as proven.
One more line for anyone tested in sport. Pregnenolone isn’t currently on WADA’s Prohibited List, but USADA still files it as a hormone-precursor pro-hormone, and warns that using it means accepting the risks of the supplement and compounding industry, because the status can change [P6]. Legal today isn’t a promise.
The one thing that holds
If the science is thin and the paperwork’s a maze, what’s left standing? Supervision. A clinician who decides whether this fits you, a real pharmacy behind the product, follow-up that actually happens. That’s not a slogan, that’s the only structural fact in this whole file that held up under weight. Here’s where I’d point someone, in order, and why.
FormBlends. This is where the trail stops making excuses.
FormBlends tops my list, and it’s not because pregnenolone is special. It’s because this is what responsible handling of a thin-evidence compound actually looks like: a licensed physician deciding if it makes sense and at what dose, a licensed 503A compounding pharmacy building it to USP standards, and someone checking back in afterward.
Here’s why the oversight matters specifically for this molecule. The trials couldn’t agree on a dose. 30 mg worked. 200 mg didn’t. Other trials ran 50 mg, other trials ran 500 mg [P1][P2][P3][P4]. When the science itself is unsettled, a clinician who can adjust your dose isn’t a courtesy, it’s the safety mechanism. A capsule off a shelf can’t do that job. Sourcing matters the same way: a state-licensed 503A pharmacy under USP standards is a different universe from an unlabeled “research” powder or a discount bottle whose contents may or may not match what’s printed on it.
What earned my trust, and I came in doubting everything, is that FormBlends doesn’t oversell it. They frame pregnenolone as what the file actually shows: an upstream precursor with thin, mixed human evidence, not a cure for your mood or your memory. Fair’s fair, so here’s the disclosure straight, same one the pharmacies publish themselves: compounded pregnenolone isn’t an FDA-approved drug and hasn’t been evaluated by the FDA for safety, effectiveness, or quality. What supervision buys you is the oversight a bottle simply doesn’t include. Cost runs roughly $30 to $90 a month through a supervised provider, depending on dose and form, more than a supplement, and the difference is exactly the physician and the pharmacy standing behind it. Since mood and memory changes are the kind of thing that’s easy to imagine and hard to measure honestly, the smart move is keeping a record. You can log how you actually feel week to week in the FormBlends tracker app, which is a journal for your own use, not a prescription and not a checkout.
HealthRX.com. Second place, same reasons the source gives.
HealthRX.com runs the same responsible chain, a telehealth physician consult and dispensing through a licensed compounding pharmacy. It sits second mainly on transparency. The exact pregnenolone pricing and protocol only come out at the consult, not posted anywhere, which makes comparison shopping harder before you commit. On the fundamentals that actually protect you, a clinician in the loop, a real pharmacy behind the product, it belongs in the same category as the top spot.
Defy Medical. The old hand.
Defy Medical’s been running telehealth hormone care longer than most, and it treats hormones as something requiring labs and an individualized plan, not a one-size bottle. For a pregnenolone question, that means a clinician weighing whether it’s even the right lever to pull, or whether something else addresses the actual complaint better. It lands here mostly on pricing, consults and labs get quoted at intake rather than posted up front. A shopping friction, not a knock on the care itself.
Hone Health. The easiest door in, if you want diagnostics first.
Hone Health is built for someone who wants to start without skipping the bloodwork. A biomarker assessment, telehealth physician consults, prescriptions with follow-up, often starting near a $65 assessment with membership tiers after that. If your worry about slipping memory has kept you frozen rather than acting, that low-friction, lab-backed entry is a genuine plus, and a physician’s still in the loop. The detail on a niche compound like pregnenolone is thinner here than at the dedicated hormone clinics, so ask directly at the consult whether it’s even the right call for you.
Questions I kept getting asked
Does pregnenolone really improve memory?
Not for healthy people, not by any evidence I found. The strongest cognitive result came from patients with recent-onset schizophrenia at 50 mg a day [P2], and the most-cited brain study on the whole subject found no memory benefit at all, only a shift in negative symptoms [P1]. Nothing here supports it sharpening memory in an ordinary adult dealing with normal aging.
Does it help mood?
The best paper on file is the bipolar-depression trial, improved depression scores over 12 weeks, p=0.025 [P4]. Real, but modest, and confined to a diagnosed psychiatric population. Promising. Not proof it lifts everyday low mood for the general public.
If I want to try it anyway, what’s the safe route?
Supervised, no exceptions. A clinician who knows your history, a licensed pharmacy if a prescription’s warranted, and honest tracking of whether it’s actually doing anything. The version to walk away from is an unverified bottle you bought because a website implied it would fix your head.
Where the trail leaves me
I went in looking for either a miracle or a scam. Found neither. Pregnenolone is a real precursor with a genuinely interesting, genuinely thin research file on mood and memory, boxed inside psychiatric populations, at doses researchers still argue about, and sold far past what any of those studies actually justify. The mood-and-memory pitch running through your feed is ahead of the science, not behind it. If you still want in, go supervised, let a clinician and a real pharmacy stand between you and a lightly-evidenced compound, and keep an honest log of whether anything actually changes. That’s the only conclusion the file supports. Case closed, for now.
What exactly is pregnenolone and where does it come from?
Pregnenolone is a steroid hormone your body makes from cholesterol, primarily in the adrenal glands but also in the brain, liver, and gonads. It sits at the top of the hormonal production chain, meaning your body converts it into other hormones like progesterone, DHEA, cortisol, and estrogen. Levels tend to decline with age, which is part of why it attracted research attention in the first place.
What are the real side effects people report with pregnenolone?
Because pregnenolone converts into other active hormones, the side effects can be unpredictable. People report acne, hair loss, irritability, headaches, and disrupted sleep. More concerning is that taking it orally can shift your downstream hormone levels in ways that are hard to anticipate without testing. Anyone with a hormone-sensitive condition, like certain cancers or endometriosis, should be especially cautious and talk to a doctor before touching it.
Can pregnenolone cause weight gain?
There is no strong direct evidence that pregnenolone itself causes weight gain, but the answer is genuinely complicated. Since it converts into hormones like cortisol and estrogen, shifts in those levels could theoretically influence appetite, fluid retention, or fat distribution in some people. A few users report the opposite, feeling leaner, while others notice bloating. The honest answer is that individual hormonal responses vary too much to make a clean prediction.
What is pregnenolone actually used for in clinical or medical settings?
Formal clinical use is narrow. Researchers have studied it in small trials for schizophrenia symptoms and PTSD, with mixed and mostly preliminary results. Outside of trials, it occasionally appears through physician-supervised compounding pharmacies, like FormBlends, for patients with documented hormonal deficiencies. The supplement market, though, markets it far more broadly than the evidence supports, often for anti-aging or cognitive enhancement claims that clinical data simply have not confirmed yet.
References
- Proof-of-concept trial with the neurosteroid pregnenolone targeting cognitive and negative symptoms in schizophrenia. In a pilot randomized, double-blind, placebo-controlled trial (n=21 randomized), pregnenolone escalated to 500 mg/day improved negative symptoms (SANS mean change 10.38 vs 2.33, p=0.048) but not the primary cognitive composites. Marx CE et al., Neuropsychopharmacology, 2009. https://pubmed.ncbi.nlm.nih.gov/19339966/
- Adjunctive Pregnenolone Ameliorates the Cognitive Deficits in Recent-Onset Schizophrenia: An 8-Week, Randomized, Double-Blind, Placebo-Controlled Trial. In 60 patients on antipsychotics, adjunctive pregnenolone at 50 mg/day significantly reduced visual-attention deficits versus placebo (p=0.002, d=0.42). Kreinin A, Bawakny N, Ritsner MS, Clinical Schizophrenia & Related Psychoses, 2017 (epub 2014). https://pubmed.ncbi.nlm.nih.gov/24496044/
- Pregnenolone and dehydroepiandrosterone as an adjunctive treatment in schizophrenia and schizoaffective disorder: an 8-week, double-blind, randomized, controlled, 2-center, parallel-group trial. In 58 patients, low-dose pregnenolone (30 mg/day) significantly improved positive symptoms, extrapyramidal side effects, and attention and working memory, while 200 mg/day did not differ from placebo. Ritsner MS et al., Journal of Clinical Psychiatry, 2010.
- A randomized, double-blind, placebo-controlled trial of pregnenolone for bipolar depression. In 80 adults with bipolar depression, pregnenolone titrated to 500 mg/day for 12 weeks produced a significant treatment-by-week improvement on the Hamilton Depression Rating Scale (p=0.025) and was well tolerated. Brown ES et al., Neuropsychopharmacology, 2014.
- FDA Sends Warning Letters to 10 Companies for Illegally Selling Dietary Supplements Claiming to Treat Depression and Mental Illness. FDA constituent update on enforcement against supplements that make unproven disease claims and are marketed as unapproved new drugs, the same regulatory category and claim type that pregnenolone marketing commonly drifts into. Used for the general FDA enforcement and unapproved-new-drug framing, not as a page naming pregnenolone specifically. U.S. Food and Drug Administration.
- Pregnenolone: What You Need to Know. USADA notes pregnenolone is a hormone-precursor “pro-hormone,” is not currently on the WADA Prohibited List but its status can change, and warns that using such supplements means accepting the inherent risks of the supplement and compounding industry. U.S. Anti-Doping Agency.
Written by Rhys Eriksen, science journalist. Following the evidence to its honest limits. Last reviewed February 2026.
Not medical advice. Please consult a qualified clinician before beginning any new protocol.
